Decision support for drug regimens for HIV-infected patients
RetroGram relates complex genomic information on HIV-1 resistance to the clinical suitability of
anti-retroviral drugs.
RetroGram generates a suitability
ranking of all FDA approved drugs based on their expected clinical efficacy for an individual patient.
A unique feature of RetroGram is that it includes the experience and opinions of experts
in the algorithm to
weigh the effect of specific genotypic changes.
RetroGram is available
both as a stand-alone Windows-based application and in a Web-enabled version.
RetroGram's clinical utility was highlighted in a large multi-centre study in Spain.
Investigators concluded in their study that
"HIV-1 genotyping interpreted by a
software package improves the virological outcome when it is added to the clinical information as a
basis for decisions on changing anti-retroviral therapy" [C Tural et al. Clinical utility of HIV-1 genotyping and expert advice: the Havana Trial. AIDS. 2002; 16:209-218].
RetroGram is currently being
used in more than ten international comparison studies of all available genotype
interpretation systems.